Tricida

Biotechs reveal layoffs, research revamps in third quarter earnings
BioPharma Dive
Wed, 11/16/22 - 11:13 pm
layoffs
Tricida
Freeline Therapeutics
Harpoon Therapeutics
Adamis Pharmaceuticals
Neoleukin
NexImmune
Tricida eyeing sale, cost-cutting options after failing high-stakes CKD wager
Endpoints
Thu, 11/3/22 - 12:00 pm
Tricida
chronic kidney disease
M&A
Tricida’s shares plunge as phase 3 fail seals fate of FDA-rejected kidney disease drug
Fierce Biotech
Mon, 10/24/22 - 11:59 am
Tricida
clinical trial
kidney disease
Veverimer
Tricida sinks as FDA rejection raises prospect of new trial
Fierce Biotech
Tue, 08/25/20 - 10:33 am
Tricida
metabolic acidosis
chronic kidney disease
clinical trials
FDA
Veverimer
The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate
Yahoo/Benzinga
Sun, 07/28/19 - 11:48 pm
biotech
earnings
Immunic
Alkermes
Conatus
Aevi Genomic
Tricida
Curis
Ultragenyx
Leap Therapeutics
Cidara Therapeutics
Akcea
Spark Therapeutics
Eli Lilly
AnaptysBio
clinical trials
It’s a record! Biotech IPO frenzy outpaces 2017 in half the time as 4 new arrivals on Nasdaq raise $556M
Endpoints
Sat, 06/30/18 - 11:42 am
biotech
IPOs
Tricida
Translate Bio
Forty Seven
Neon Therapeutics
Aquestive Therapeutics
The Biotech IPO Rush Continues With Four More Coming Soon
CP Wire
Tue, 06/26/18 - 05:31 pm
biotech
IPOs
Neon Therapeutics
Forty Seven
Translate Bio
Tricida
The Biotech IPO Rush Continues With Four More Coming Soon
Wed, 06/27/18 - 10:30 am
biotech
IPOs
Neon Therapeutics
Forty Seven
Translate Bio
Tricida
Tricida Announces Positive Ph III Results for First in Class Drug for Chronic Kidney Disease Related Metabolic Acidosis
CP Wire
Tue, 06/5/18 - 10:25 am
Tricida
chronic kidney disease
metabolic acidosis
TRC101
Tricida Announces Positive Ph III Results for First in Class Drug for Chronic Kidney Disease Related Metabolic Acidosis
Tue, 06/5/18 - 09:24 am
Tricida
chronic kidney disease